[HTML][HTML] Evaluating the impact of in silico predictors on clinical variant classification
EH Wilcox, M Sarmady, B Wulf, MW Wright… - Genetics in …, 2022 - Elsevier
Purpose According to the American College of Medical Genetics and Genomics/Association
of Medical Pathology (ACMG/AMP) guidelines, in silico evidence is applied at the …
of Medical Pathology (ACMG/AMP) guidelines, in silico evidence is applied at the …
[HTML][HTML] ClinGen Variant Curation Interface: a variant classification platform for the application of evidence criteria from ACMG/AMP guidelines
…, SM Harrison, JL Goldstein, X Luo, H Wand, B Wulf… - Genome medicine, 2022 - Springer
Background Identification of clinically significant genetic alterations involved in human
disease has been dramatically accelerated by developments in next-generation sequencing …
disease has been dramatically accelerated by developments in next-generation sequencing …
Generating Clinical-Grade Gene–Disease Validity Classifications Through the ClinGen Data Platforms
…, G Cheung, ME Mandell, B Wulf… - Annual Review of …, 2024 - annualreviews.org
Clinical genetic laboratories must have access to clinically validated biomedical data for
precision medicine. A lack of accessibility, normalized structure, and consistency in evaluation …
precision medicine. A lack of accessibility, normalized structure, and consistency in evaluation …
LitGen: Genetic literature recommendation guided by human explanations
As genetic sequencing costs decrease, the lack of clinical interpretation of variants has become
the bottleneck in using genetics data. A major rate limiting step in clinical interpretation is …
the bottleneck in using genetics data. A major rate limiting step in clinical interpretation is …
ClinGen Variant Curation Interface: A Variant Classification Platform for the Application of Evidence Criteria from ACMG/AMP Guidelines
…, SM Harrison, JL Goldstein, X Luo, H Wand, B Wulf… - medRxiv, 2021 - medrxiv.org
Background Identification of clinically significant genetic alterations involved in human
disease has been dramatically accelerated by developments in next-generation sequencing …
disease has been dramatically accelerated by developments in next-generation sequencing …
[HTML][HTML] P673: Batch ClinVar submission support in ClinGen's Variant Curation Interface (VCI)
…, K Dalton, G Cheung, M Mandell, B Wulf… - Genetics in Medicine …, 2023 - gimopen.org
Methods Here we present the first in a series of planned software features to provide a better
ClinVar submission experience for VCI users. This batch submission feature allows users to …
ClinVar submission experience for VCI users. This batch submission feature allows users to …
[BOOK][B] The CIA and the Cult of Intelligence
V Marchetti, JD Marks, ML Wulf - 1974 - academia.edu
… John Shattuck, Mimi Schneider, and others, but especially Mel Wulf-provided more than free
counsel and an effective legal defense of our constitutional rights. They have been friends of the …
counsel and an effective legal defense of our constitutional rights. They have been friends of the …
Nitric oxide release and contractile properties of skeletal muscles from mice deficient in type III NOS
…, WE O'Brien, AR Gregg, RM Bryan Jr… - American Journal …, 2000 - journals.physiology.org
Skeletal muscle constitutively expresses both the type I (neuronal) and type III (endothelial)
isoforms of nitric oxide synthase (NOS). We tested the functional importance of type III NOS …
isoforms of nitric oxide synthase (NOS). We tested the functional importance of type III NOS …
[PDF][PDF] Identifying biomarkers of differential chemotherapy response in TNBC patient-derived xenografts with a CTD/WGCNA approach
Although systemic chemotherapy remains the standard of care for TNBC, even combination
chemotherapy is often ineffective. The identification of biomarkers for differential …
chemotherapy is often ineffective. The identification of biomarkers for differential …
A genome-wide association study of myasthenia gravis
…, MW Nicolle, RM Pascuzzi, A Pestronk, C Wulf… - JAMA …, 2015 - jamanetwork.com
Importance Myasthenia gravis is a chronic, autoimmune, neuromuscular disease characterized
by fluctuating weakness of voluntary muscle groups. Although genetic factors are known …
by fluctuating weakness of voluntary muscle groups. Although genetic factors are known …